FDA Approves IBS-C Treatment Linzess (IRWD) (FRX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
UPDATE: Ironwood (IRWD), Forest (FRX) Win FDA Approval for Linzess
August 30, 2012 10:58 AM EDT(Updated - August 30, 2012 10:59 AM EDT)
Ironwood Pharmaceuticals (NASDAQ: IRWD), Forest Labs (NYSE: FRX) win FDA approval for Linzess to treat irritable bowel. (NOTE: Shares of IRWD were halted)... More
